Telithromycin

146 interactions 11 explained in plain English
Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated Jul 4, 2026 · Editorial policy · Data sources

Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →

Most serious with: Ketoconazole Topical Lovastatin Alfuzosin Dihydroergotamine Injection Finerenone Simvastatin
13 Contraindicated 122 Major 11 Moderate
All (146) Contraindicated (13) Major (122) Moderate (11)

Contraindicated

Telithromycin Colchicine Colcrys Explained Increased colchicine exposure and an increased risk of fatal toxicity Details Telithromycin Simvastatin Flolipid Explained Increased risk of myopathy or rhabdomyolysis Details Telithromycin Alfuzosin UroXatral Increased alfuzosin plasma concentrations and an increased risk of QT interval prolongation Details Telithromycin Dihydroergotamine Injection DHE-45® Injection An increased risk of acute ergot toxicity Details Telithromycin Dihydroergotamine Nasal Spray Migranal An increased risk of acute ergot toxicity Details Telithromycin Finerenone Kerendia Increased finerenone exposure and an increased risk of finerenone-related adverse effects Details Telithromycin Ivabradine Corlanor Increased ivabradine exposure, an increased risk of ivabradine-related adverse effects and an increased risk of QT prolongation Details Telithromycin Ketoconazole Topical Extina® Foam Increased telithromycin exposure, an increased ketoconazole exposure and an increased risk for QT interval prolongation Details Telithromycin Lovastatin Altocor® Increased lovastatin plasma levels and an increased risk of myopathy or rhabdomyolysis Details Telithromycin Lurasidone Latuda Increased lurasidone exposure Details Telithromycin Methylergonovine Methergine An increased risk of acute ergot toxicity Details Telithromycin Naloxegol Movantik Increased naloxegol exposure and an increased risk of naloxegol-related adverse effects Details Telithromycin Nimodipine Nimotop Increased serum nimodipine concentrations Details

Check another drug

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.